Rybelsus 14 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FBCL7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,815
Award facts
- Contract value 100% obligated
- $23,815.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,815.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for supply of Rybelsus 14 mg tablets in quantities of 30 units. This non-competitive delivery order, effective July 21, 2025, with ultimate completion by July 22, 2025, represents a small-value pharmaceutical transaction under the company's broader federal medical supply contract portfolio. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its extensive relationships with the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical supplies, and specialized pharmaceuticals to military healthcare programs worldwide. AmerisourceBergen Drug Corp's consistent receipt of non-set-aside, competitively awarded delivery orders demonstrates its established capability to fulfill federal medical procurement requirements, with transaction values ranging from under $100 to over $45,000 across multiple therapeutic domains including diabetes management, neurology, pain management, and infectious disease treatments.
Quick answers
Who was awarded contract SPE2DB25FBCL7?
SPE2DB25FBCL7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FBCL7 worth?
The government has obligated $23,815 on SPE2DB25FBCL7.
Is contract SPE2DB25FBCL7 an order under another contract?
Yes. SPE2DB25FBCL7 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBCL7 competed?
The extent of competition for SPE2DB25FBCL7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award